[Clinical use of labor inhibiting substances].
D000605:Amino Alcohols / Q000627:therapeutic use; D005260:Female; D005859:Germany, East; D006801:Humans; D007226:Infant Mortality; D009756:Nylidrin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D010627:Phenethylamines / Q000627:therapeutic use; D010636:Phenols / Q000627:therapeutic use; D011247:Pregnancy; D012118:Resorcinols / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use; D013997:Time Factors
D000605:Amino Alcohols; D010627:Phenethylamines; D010636:Phenols; D012118:Resorcinols; D013566:Sympathomimetics; D009756:Nylidrin
Zur klinischen Anwendung von wehenhemmenden Substanzen.